Replies to post #369336 on Innovation Pharmaceuticals Inc (IPIX)

[farrell90]

BioNTech is quite a company. Their primary source of income is from the Covid Vaccine, but they are involved in 80 clinical trials, many involve therapeutic vaccines against cancer.

https://clinicaltrials.gov/ct2/results?cond=&term=biontech&cntry=&state=&city=&dist=

If IPIX Brilacidin proves to be equally successful it would be interesting to see if they could expand the research on synthetic defensin mimetics. It is my understanding IPIX controls all the technical information and computer programs to make compounds similar to Brilacidin.

Perhaps they could merge with DeGrado's company,Pliant Therapeutics and engage some of the original Polymedixs researchers.

https://pliantrx.com/team/bill-degrado-ph-d/

I doubt that makes much business sense , but it would be great to develop new drugs with the background laid by Polymedixs.

GLTA Farrell

[loanranger]

I don't think you can use that info alone to reach that conclusion. BioNtech gets 50% of the gross profits.

https://investors.pfizer.com/investor-news/press-release-details/2021/PFIZER-REPORTS-SECOND-QUARTER-2021-RESULTS/default.aspx